Eve Burstein
Stock Analyst at Bernstein
(2.90)
# 1,726
Out of 4,761 analysts
21
Total ratings
46.15%
Success rate
11.9%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $160 → $200 | $162.31 | +23.22% | 4 | Jan 10, 2025 | |
| A Agilent Technologies | Maintains: Market Perform | $140 → $135 | $135.37 | -0.27% | 2 | Nov 26, 2024 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $113.84 | +27.37% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $374.82 | -3.95% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $49.26 | +82.70% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $42.87 | -18.36% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $532.55 | +16.42% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.54 | +62.34% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $17.30 | +27.17% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $94.20 | +17.83% | 1 | Sep 28, 2023 |
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $162.31
Upside: +23.22%
Agilent Technologies
Nov 26, 2024
Maintains: Market Perform
Price Target: $140 → $135
Current: $135.37
Upside: -0.27%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $113.84
Upside: +27.37%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $374.82
Upside: -3.95%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $49.26
Upside: +82.70%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $42.87
Upside: -18.36%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $532.55
Upside: +16.42%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.54
Upside: +62.34%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $17.30
Upside: +27.17%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $94.20
Upside: +17.83%